[38F3-38F3];[39A2-39A2];
A set of isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Initial set of 519 isogenic deletions provides 56% genome coverage.
The current Exelixis collection at the Bloomington Stock Center differs from the original described in FBrf0175003 : a significant number were shown not to carry a deletion and have been removed from the collection; a number of stocks have been lost; a number of additional deletions are included that were generated after publication.
38F3;39A2
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Fails to complement Df(2L)BSC302.
Inferred to overlap with: Df(2L)BSC302.
Inferred to overlap with: Df(2L)BSC333.
Fails to complement Df(2L)BSC105. Inferred to overlap with: Df(2L)BSC105.
Homozygous Df(2L)Exel7080 mutant embryos produce a bypass phenotype in which 14% of hemisegments have no intersegmental nerve b (ISNb) axons that grow into the ventrolateral muscle (VLM) field.